Prognostic Impact of the Addition of Prostate-Directed Radiotherapy With or Without Metastasis-Directed Radiotherapy Under Upfront Doublet Therapy for High-Volume Metastatic Hormone-Sensitive Prostate Cancer.
- DOI
- 10.1002/pros.70238
- Published
- 2026 Aug 23
- Container
- The Prostate
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/pros.70238,
title = {Prognostic Impact of the Addition of Prostate-Directed Radiotherapy With or Without Metastasis-Directed Radiotherapy Under Upfront Doublet Therapy for High-Volume Metastatic Hormone-Sensitive Prostate Cancer.},
author = {Koguchi D and Tsumura H and Tabata KI and Satoh T and Shiono Y and Hirano S and Ikeda M and Yamada Y and Matsushita K and Tanaka R and Ishii D and Ishiyama H and Matsumoto K},
year = {2026},
journal = {The Prostate},
doi = {10.1002/pros.70238},
url = {https://doi.org/10.1002/pros.70238}
}RIS
TY - JOUR TI - Prognostic Impact of the Addition of Prostate-Directed Radiotherapy With or Without Metastasis-Directed Radiotherapy Under Upfront Doublet Therapy for High-Volume Metastatic Hormone-Sensitive Prostate Cancer. AU - Koguchi D AU - Tsumura H AU - Tabata KI AU - Satoh T AU - Shiono Y AU - Hirano S AU - Ikeda M AU - Yamada Y AU - Matsushita K AU - Tanaka R AU - Ishii D AU - Ishiyama H AU - Matsumoto K PY - 2026 JO - The Prostate DO - 10.1002/pros.70238 UR - https://doi.org/10.1002/pros.70238 ER -
APA
D, K., H, T., KI, T., T, S., Y, S., S, H., M, I., Y, Y., K, M., R, T., D, I., H, I., & K, M. (2026). Prognostic Impact of the Addition of Prostate-Directed Radiotherapy With or Without Metastasis-Directed Radiotherapy Under Upfront Doublet Therapy for High-Volume Metastatic Hormone-Sensitive Prostate Cancer.. The Prostate. https://doi.org/10.1002/pros.70238
Source records
- pubmed · retrieved 2026-09-26T16:04:49.046Z